Related Experiment Video
Updated: Jul 3, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Treatment of lysosomal storage disorders: focus on the neuronal ceroid-lipofuscinoses
Chris Pierret1, Jason A Morrison, Mark D Kirk
1Division of Biological Sciences, University of Missouri, Columbia, MO 65211, USA.
Abstract:
Recent advances in our understanding of lysosomal storage disorders (LSDs) may lead to new therapies to treat the neuronal ceroid-lipofuscinoses (NCLs). In this review, enzyme replacement therapy, gene therapy, cell-mediated therapy and pharmaceutical treatments are considered across the LSDs and extended to therapies for the NCLs. It is likely that a combination of approaches will produce the most beneficial clinical outcome for treatment of pathologies displayed by the NCLs.
Related Concept Videos
Lysosomal Hydrolases
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Parkinson's Disease: Overview
Lysosomes
Lysosomes
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
